Delcath Systems Community

Key Takeaways Expansion of treatment centers and pipeline therapies positions Delcath for significant revenue growth and reduced concentration risk across multiple cancer indications. Strengthening clinical evidence and favorable healthcare trends drive broader adoption, pricing power, and sustainable earnings growth in domestic and global markets.